This quarter’s newsletter features a great read by our Managing Partner Trevor Price discussing culture and leadership lessons learned from Evolent Health and Health Catalyst, and an article by Associate Ellen Halle on the implications of global health practices, applied domestically by our clients Privia Health and Iora Health. Hope you enjoy!
Oxeon is excited to announce that Accolade has joined our client portfolio. Backed by Comcast Ventures, Accretive LLC and Carrick Capital Partners, Accolade is an innovative built-for-purpose company focused on improving member engagement and health outcomes while lowering cost for large employers, payers and accountable care organizations.
Oxeon is pleased to announce Dave Fielding, previously of Steward Health Care, as Chief Financial Officer of Iora Health, where he joins the leadership team led by CEO and Co-Founder Rushika Fernandopulle. An Oxeon portfolio investment, Iora Health is building a new model of primary health care delivery from the ground up, and is additionally funded by Fidelity Biosciences, Polaris Partners, .406 Ventures and Tony Hsieh, among others.
Oxeon Partners is excited to announce Pager as a recent addition to both our client and investment portfolios. Based in NYC, the company is also funded by Lux Capital and Montage Ventures.
Avalon Healthcare Solutions has named Gordon Sween to its senior leadership team, where he will serve at Chief Operating Officer for the company, led by CEO Dr. Bill Kerr and President Dr. Jon Gavras. Backed by Francisco Partners, Avalon is the first and only comprehensive laboratory benefits management solution in the healthcare industry, and is a portfolio investment of Oxeon Investments LLC.
Huge congratulations to Oxeon friend, client & investment Privia Health on their recent $400M financing! The Virginia-based physician practice management and population health technology company received funding from a Goldman Sachs-led investor group to enable the business' national expansion.